Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
KEYNOTE-045: Pembrolizumab Maintains Overall Survival Benefit in Urothelial Cancer
29 septembra, 2020 8:30 pmJune 5, 2017 The PD-L1 inhibitor pembrolizumab continued to demonstrate an overall survival (OS) benefit compared with chemotherapy among...
Cancer predisposing germline mutations in patients (pts) with urothelial cancer (UC) of the renal pelvis (R-P), ureter (U) and bladder (B)
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 4510 Citation: J Clin Oncol 35,...
DNA damage repair and response (DDR) gene alterations (alt) and response to PD1/PDL1 blockade in platinum-treated metastatic urothelial carcinoma (mUC)
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 4509 Citation: J Clin Oncol 35,...
Genomics May Provide New Insight Into Bladder Cancer Treatments
29 septembra, 2020 8:30 pmJune 4, 2017 In patients with upper tract urothelial carcinoma (UC) or who have early onset bladder cancer, screening...
SPRÁVA Z VÝROČNEJ KONFERENCIE AMERICKEJ ONKOLOGICKEJ SPOLOČNOSTI 2017 Genitourinárne malignity
29 septembra, 2020 8:30 pmV dňoch 2. – 6. júna 2017 sa v americkom Chicagu uskutočnila výročná konferencia Americkej onkologickej spoločnosti (ASCO). Tak ako každý rok,...
Overall survival results of ICON6: A trial of chemotherapy and cediranib in relapsed ovarian cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5506 Citation: J Clin Oncol 35, 2017...
Circulating tumor DNA analysis using targeted sequencing of 508 clinically actionable genes in patients with high grade serous ovarian cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5582 Citation: J Clin Oncol 35, 2017...
A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5505 Citation: J Clin Oncol 35, 2017...
Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5502 Citation: J Clin Oncol 35, 2017...
Treatment and outcomes of small cell neuroendocrine carcinoma of the cervix (SCCC)
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5531 Citation: J Clin Oncol 35, 2017...